The challenges and successes of implementing a sustainable antimicrobial resistance surveillance programme in Nepal

[1]  J. Paul.  BMC public health. , 2012, World health & population.

[2]  S. Malla,et al.  Antimicrobial susceptibilities of enteric bacterial pathogens isolated in Kathmandu, Nepal, during 2002-2004. , 2011, Journal of infection in developing countries.

[3]  S. Shrestha,et al.  Antibiotic susceptibility patterns of Vibrio cholerae isolates. , 2010, JNMA; journal of the Nepal Medical Association.

[4]  S. Malla,et al.  Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal. , 2010, Japanese journal of infectious diseases.

[5]  S. P. Dumre,et al.  Asymptomatic throat carriage rate and antimicrobial resistance pattern of Streptococcus pyogenes in Nepalese school children. , 2010, Kathmandu University medical journal.

[6]  Dwij Raj Bhatta,et al.  Multidrug resistant Salmonella enterica serovar typhi. , 2009, JNMA; journal of the Nepal Medical Association.

[7]  S. Malla,et al.  Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern. , 2007, Kathmandu University medical journal.

[8]  N. Bhattarai,et al.  Prevalence of Shigella species and their antimicrobial resistance patterns in Eastern Nepal. , 2005, Journal of health, population, and nutrition.

[9]  S. Malla,et al.  A Pilot Study on Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Nepal , 2005, Sexually transmitted diseases.

[10]  M. Lewis,et al.  Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Kansakar,et al.  Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. , 2005, JNMA; journal of the Nepal Medical Association.

[12]  J. Coast,et al.  Antimicrobial resistance: a global response. , 2002, Bulletin of the World Health Organization.

[13]  A. Siitonen,et al.  Detection of Decreased Fluoroquinolone Susceptibility in Salmonellas and Validation of Nalidixic Acid Screening Test , 1999, Journal of Clinical Microbiology.

[14]  J. Coast,et al.  Superbugs: should antimicrobial resistance be included as a cost in economic evaluation? , 1996, Health economics.

[15]  J. Coast,et al.  Over-the-counter antimicrobials: the hidden costs of resistance. , 1996, The Journal of antimicrobial chemotherapy.

[16]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.